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Abstract
One way in which the human immunodeficiency virus (HIV-1) replicates within a host is by infecting activated
CD4+ T-cells, which then produce additional copies of the virus. Even with the introduction of antiretroviral
drug therapy, which has been very successful over the past decade, a large obstacle to the complete eradication
of the virus is the presence of viral reservoirs in the form of latently infected CD4+ T-cells. We consider a
model of HIV infection that describes T-cell and viral interactions, as well as, the production and activation
of latently infected T-cells. Upon determining equilibrium states of the latent cell model, the local and global
asymptotic behavior of solutions is examined, and the basic reproduction number of the system is computed
to be strictly less than that of the corresponding three-component model, which omits the effects of latent
infection. In particular, this implies that a wider variety of parameter values will lead to viral eradication as
t →∞ due to the appearance of latent CD4+ T-cells. With this realization we discuss possible alternative
notions for eradication and persistence of infection other than traditional tools. These results are further
illustrated by a number of numerical simulations.
Keywords: HIV-1, Mathematical model, Latently infected T-cells, Antiretroviral therapy, Global
asymptotic stability
1. Introduction
The majority of cells infected with the human immunodeficiency virus (HIV-1) are activated CD4+
T-cells. Once infected, these cells produce additional copies of virus, thereby prolonging the infection.
Upon detecting such an infection, the immune system mounts a complex adaptive response, controlling
the virus population to a limited extent. Further control is available in the form of antiretroviral drugs,
such as Reverse Transcriptase Inhibitors (RTIs) and Protease Inhibitors (PIs) [17]. If such drugs are taken
with sufficient frequency, the virus population is largely limited and remains below the level of detection [6].
However, antiretroviral therapy (ART) cannot fully eradicate the virus, as viral rebound occurs once therapy
is interrupted [1, 12] A number of factors have been proposed to explain this viral rebound. Most notably,
it has been suggested that HIV lay dormant within a number of reservoirs. Primary among these reservoirs
are latently infected CD4+ T-cells [2]. Though latently infected T-cells exist in the body with a much
lower frequency than susceptible CD4+ T-cells, the reservoir appears to decay very slowly, with a half-life
measured between 6 and 48 months [26]. Although infected, these cells do not produce new virions until
activated, thus potentially providing a longer-lived hiding place where the virus may evade control by either
the immune system or antiretroviral treatment [2]. Consequently, in this paper, we analyze a mathematical
model that includes latent infection and examine the control of infection by ART. We also assume that such
latent T-cells exist significantly longer than productively infected CD4+ T-cells. Ultimately, we will show
that a mathematical analysis of the most basic latent model demonstrates that the inclusion of such cells
increases the likelihood for viral clearance under the traditional approach of analyzing the basic reproduction
number and the associated stability of equilibria. While this will seem intuitive from a modeling perspective,
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as described later, it also appears contradictory to the widely-held notion that latently infected T-cells are
an important mechanism for the inability of ART to eradicate an established infection. What this really
implies is that standard mathematical tools are insufficient to realistically describe the dynamics of HIV
when latent cells are considered. Instead, one must focus on the rate of decay of the infection, which is
significantly slowed by the latent T-cell population.
A number of authors have studied the biological aspects of mathematical models concerning HIV dynamics
that consider latently infected cells. Notably, Callaway and Perelson [4] studied low-level viremia, Rong and
Perelson [28] modeled viral blips and showed that a latent reservoir could produce viral transients when
activated by infection, while Sedaghat et al. [31] employed a simple model for the dynamics of the latent
reservoir to show that its stability was unlikely to stem from ongoing replication during ART. In each of
these studies, a reduced or linearized mathematical analysis was performed, but the nonlinear behavior of
the associated model was not fully elucidated. In the current study, we describe latently infected cells using
a separate compartment, as did these authors, by assuming that a proportion of newly-infected cells become
latently infected upon contact with the virus, but that they are not productively infected until they leave
the latent state, which occurs at a rate α proportionate to the strength of the latent cell population. We
note that the effects of viral mutation, which may continuously change model and parameter values, and
the possible spatial dependence of parameters are ignored. Using this model, we study the influence of the
latent reservoir on the persistence of HIV infection and viral rebound. Our results provide a new perspective
on the methods of mathematical and stability analysis for viral and latent reservoir persistence.
The paper proceeds as follows. In the next section, we will review some known results concerning the
standard three-component model of HIV dynamics. In Section 3, we introduce an additional population
representing latently infected CD4+ T-cells, and study the effects that these cells have on the structure and
behavior of the long-time dynamics of the model. In Section 4, we discuss the ramifications of our results
and, in particular, the need to construct more precise notions of viral eradication and persistence. The fifth
section contains proofs of the theorems contained within previous sections. In the final section, we conclude
with a discussion of our results.
2. The Three-component model
In general, the modeling of HIV dynamics in vivo is complicated by the appearance of spatial inhomo-
geneities, which can arise from various reservoirs, such as those occurring within lymphatic tissues [19, 25].
Even when such inhomogeneities are ignored, however, these systems are often described to a sufficient degree
by systems of ordinary differential equations that include no spatial dependence. We begin by considering
a three-component model for the evolution of within-host HIV, that does not include spatial fluctuations
or effects due to long-lived infected or latently infected cells. This model has been widely-accepted as a
descriptive representation for the basic dynamics of HIV [3, 24, 35]. It represents the populations of three
components in a fixed volume at a given time t: T (t), the number of CD4+ T-cells that are susceptible to
HIV-1 infection, I(t) the number of infected T-cells that are actively producing virus particles, and V (t) the
number of free virions. These quantities approximately satisfy the system of ordinary differential equations
(1)


dT
dt
= λ− dTT − kTV
dI
dt
= kTV − dII
dV
dt
= NdII − dV V.
Here λ is the recruitment rate of susceptible T-cells and dT is their mortality rate. The constant k represents
the rate of infection, which is included within a bilinear mass action term, while dI is the death rate of
productively infected cells and dV is the clearance rate of free virus. The parameter N is the burst size, i.e.
the total number of virions produced by an infected cell during its life span.
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Figure 1: A representative solution of (1) with parameter values stated in Table 1. The initial T-cell
population is T (0) = 4 × 105, while the initial viral load is V (0) = 105, and I(0) = 0. In this example, the
system tends to the endemic equilibrium as t→∞ because R0 = 2.087.
The behavior of solutions to these equations has previously been analyzed in great detail [3,33,35,36]. In
particular, it is known that exactly two steady states exist, which we will write in the form (T, I, V ), namely
a non-infective equilibrium
ENI :
(
λ
dT
, 0, 0
)
and an infective or endemic equilibrium
EI :
(
λ
dTR0
,
dT dV
kNdI
(R0 − 1),
dT
k
(R0 − 1)
)
where
R0 =
λkN
dV dT
.
The stability properties of these steady states are also well-known and depend only upon the single parameter
R0, called the basic reproduction number. In particular, one can study the linearized analogue of (1) and
prove the local asymptotic stability of ENI if R0 ≤ 1 and the local asymptotic stability of EI if R0 > 1
[36]. This result effectively states that for starting values of the populations which are close enough to
the given equilibria, the solutions will tend to the respective equilibrium point as t → ∞. Additionally,
the global asymptotic stability of these equilibria is known. In [20] it was shown that initial populations
are irrelevant in determining the long term dynamics of the solution. More specifically, if R0 ≤ 1, then
for any initial population of uninfected cells, infected cells, and virions the solutions of (1) tend to ENI as
t →∞. Contrastingly, if R0 > 1 the same result holds for the endemic equilibrium EI . Figure 1 displays a
representative graph of solutions for which R0 > 1 and hence viral infection persists.
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3. Inclusion of Latently-infected cells
Though (1) describes the basic mechanisms which account for the spread of HIV, it lacks the ability
to describe the latent stage of a specific subpopulation of infected T-cells. Many studies [7, 9, 10] have
determined that upon infection and transcription of viral RNA into cell DNA, a fraction of CD4+ T-cells
fail to actively produce virus until they are activated, possibly years after their initial infection. Such
cells may possess a much longer lifespan than their counterparts, and are termed latently infected. Upon
activation, latently infected cells do become actively productive, and hence begin to increase the viral load
through viral replication. A basic model of latent cell activation was initially developed to examine cell
populations that contribute to the viral decline that occurs after administration of antiretroviral therapy
[23]. However, within [23] and other articles by related authors [24,28,29], the mathematical analysis of the
model is performed under a number of limiting assumptions, including a constant background population
of susceptible T-cells and perfect efficacy of anti-retroviral drugs. Thus, we focus on rigorously proving the
resulting nonlinear dynamics without these assumptions.
As for (1) we consider a model describing T-cells that may be susceptible or infected. In addition, we
let L(t) represent the new population of latently infected T-cells that cannot produce virions at time t but
begin to do so once they are activated by recall antigens. With this addition, the previously described
three-component model now contains four components and is given by
(2)


dT
dt
= λ− dTT − kTV
dI
dt
= (1− p)kTV + αL− dII
dL
dt
= pkTV − αL− dLL
dV
dt
= NdII − dV V.
Here, p ∈ (0, 1) is the proportion of infections that lead to the production of a latently infected T-cell, rather
than a productively infected T-cell, and α is the rate at which latently infected cells transition to become
actively productive. Additionally, dL is the rate at which latent cells are cleared from the system. Figure
2 displays a representative graph of solutions to (2) for which R > 1. We note that the oscillations of T, I,
and V seem quite damped in comparison to those of Figure 1.
3.1. Model Parameters
In this section and the previous one, we have adopted parameter values from other studies. A few of
the parameters possess generally agreed upon values, including λ, dT , dI , and dV . However, it should be
noted that λ and dT are typically estimated for healthy individuals, and thus may not be reliable estimates
to describe values within HIV patients, especially for those who experience impaired thymic function [18].
Obviously, there are many parameters, and these are summarized within Table 1, along with descriptions of
the variables, their associated units, and references from which parameter values stem.
The parameter that displays the most uncertainty within the literature is the viral infectivity k which
fluctuates by an order of magnitude from a value of 2.4 × 10−8 ml/day [24, 28] to 2.7 × 10−7 ml/day [34].
The value we utilize here is at the low end of this range and stems from [24]. Biologically relevant values of
the in vivo burst size N are also somewhat uncertain. Estimates based on counting HIV-1 RNA molecules
in an infected cell vary between hundreds and thousands [15,16,28], and estimates based on viral production
have been as high as 5× 104 [5, 11]. Here, we choose N = 2000 HIV-1 RNA/cell as reported in [16].
Parameters that stem specifically from (2) are generally not well-known. In particular, the fraction of new
viral infections resulting in latency α varies from study to study, but based on previous work [4, 18], we use
α = 0.01 per day. Similarly, the removal rate of latently infected cells, dL, has been discussed as anywhere
from 10−3 per day [28] to 0.24 per day [34]. Hence, we chose a value with this range, namely dL = 4× 10
−3
per day, as reported within [14]. The proportion p of cells which are categorized as latent upon becoming
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Figure 2: A representative solution of (2) with parameters from Table 1. The initial values are T (0) = 4×105,
V (0) = 105, and I(0) = L(0) = 0. In this example, the system tends to the endemic equilibrium as t → ∞
because RL = 2.027.
infected also differs throughout recent studies, ranging from 1.5× 10−6 in [4] to 0.1 in [34]. In this case, we
utilize the latter value so as to emphasize changes in (1) due to the latent cell population. Initial conditions
of the proposed model are chosen to match clinically observed decay characteristics of the latent reservoir
and the virus population. In particular, we utilize values similar to [4], namely T (0) = 4 × 105, I(0) = 0,
L(0) = 0, and V (0) = 105. Next, we analyze properties of solutions to (2) so as to compare their dynamics
and large time behavior with solutions of (1).
3.2. Analysis and properties of solutions
As a first step, we can say with certainty that biologically reasonable values of the parameters give rise
to positive populations assuming that at some earlier point (perhaps at the initial time) the populations
possessed positive values.
Theorem 3.1. Assume all constants in (2) are nonnegative and the initial values T (0), I(0), L(0), and V (0)
are positive. Then, the solutions of (2), namely T (t), I(t), L(t), and V (t) exist, are unique, and remain
bounded on the interval [0, t∗] for any t∗ > 0. Additionally, each function remains positive for any t ≥ 0.
Of course, the requirement of initial positivity is not completely necessary since we may translate or
rescale the time variable to alter the initial time. Hence, what is necessary for the theorem to hold is that all
populations must attain positive values at some time. This result provides some general validation for the
model since it implies that negative population values cannot occur if one begins with biologically reasonable
(i.e., positive) values.
Next, we proceed as for (1) and investigate the possible equilibrium states of (2) and their stability
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Table 1: Variable and parameter values for (1) and (2).
Variable Units Description Value Reference
T (t) cells ml−1 Susceptible CD4+ T-cells – –
I(t) cells ml−1 Actively Infected CD4+ T-cells – –
L(t) cells ml−1 Latently Infected CD4+ T-cells – –
V (t) virions ml−1 Infectious virions – –
λ ml−1 day−1 Production rate of CD4+ T-cells 104 [4]
dT day
−1 Death rate of susceptible T cells 0.01 [21]
dI day
−1 Death rate of actively infected T cells 1 [22]
dV day
−1 Clearance rate of virions 23 [27]
k ml day−1 Rate of infection of susceptible cells 2.4× 10−8 [24]
N - Burst rate of actively infected T-cells 2000 [16]
dL day
−1 Death rate of latent cells 4× 10−3 [14]
α day−1 Activation rate of latent cells 0.01 [4]
p - Proportion of latent infection 0.1 [34]
ǫRT - Efficacy of RT inhibitor varies –
ǫPI - Efficacy of protease inhibitor varies –
properties. We find steady states by solving the nonlinear system of algebraic equations
(3)


0 = λ− dTT − kTV
0 = (1 − p)kTV + αL− dII
0 = pkTV − αL − dLL
0 = NdII − dV V.
for the unknown constants T, I, L, and V in terms of the parameters λ, k, p, α,N, dT , dI , dL, and dV . This
is a nontrivial task, but eventually we find the existence of exactly two steady states. We begin by solving
for the nonlinear interaction term in the first equation so that
kTV = λ− dTT.
With this, we may solve for L, I, and hence V in terms of T alone. From the third equation, pkTV = (dL+α)L
and thus
L =
p
dL + α
(λ− dTT ) .
Next, in the second equation, we find (1− p)kTV = −αL+ dII and thus
I =
1
dI
(
1− p+
αp
dL + α
)
(λ− dTT ).
The last equation yields V in terms of I, whence T , so that
V =
NdI
dV
I =
N
dV
(
1− p+
αp
dL + α
)
(λ− dTT ).
Finally, we may use the representation of V in terms of T within the first equation and solve a simple
quadratic in T to determine the possible steady state values. With this, the first equation becomes
0 = λ− dTT −
kN
dV
(
1− p+
αp
dL + α
)
(λ− dTT )T
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and it follows that the only solutions are
T =
λ
dT
and T =
λ
dT
·
1
RL
where
(4) RL =
kNλ
dT dV
·
(1− p)dL + α
dL + α
.
Continuing in this manner, we obtain two corresponding values for I, L, and V . To summarize, we find two
equilibria, which we write in the form (T, I, L, V ) as
ENI :
(
λ
dT
, 0, 0, 0
)
EI :
(
λ
dTRL
,
dTdV
kNdI
(RL − 1),
pλ
RL(dL + α)
(RL − 1),
dT
k
(RL − 1)
)
.
As before, we denote the non-infective equilibrium by ENI and the infective equilibrium by EI . Notice
that the limiting values of T, I, and V for the infective state are of the same form as those of (1), with RL
replacing the role of R0. Additionally, we see that if RL = 1, then the equilibria coincide, and if RL < 1, then
the endemic equilibrium corresponds to negative values which, in view of Theorem 3.1, cannot be obtained
from biologically relevant initial data.
By studying the linearized version of the system, we may examine the local stability of these equilibria
and find that their behavior mimics that of (1).
Theorem 3.2. If RL ≤ 1, then the non-infective equilibrium is locally asymptotically stable. If RL > 1 then
the non-infective equilibrium is an unstable saddle point, and the endemic equilibrium is locally asymptotically
stable.
Therefore, if RL ≤ 1 and population values begin within a sufficiently close distance of ENI , then they
will tend to ENI as t → ∞. Contrastingly, if RL > 1 and initial populations are sufficiently close to EI ,
they will tend to EI in the long run. Theorem 3.2 also emphasizes the crucial feature that equilibria are not
stable simultaneously, that is, bistability of ENI and EI does not occur. Furthermore, it expresses that the
qualitative behavior of system (2) changes exactly when RL transitions from less than one to greater than
one, and hence a bifurcation occurs at RL = 1.
The final theorem of the section demonstrates the stronger result that initial values of these populations
have no effect on their long term (t→∞) limiting values.
Theorem 3.3. If RL ≤ 1, then the non-infective equilibrium is globally asymptotically stable. If RL > 1,
then the endemic equilibrium is globally asymptotically stable.
This analysis reveals one very important fact about the overall system: the end states of populations are
only dependent on the value of RL, and not any other parameter or initial value. If RL is greater than one,
then the system tends to EI , an end state with a non-zero population of infected cells and virions, but if RL
is less than one, then the final equilibrium is ENI , which contains neither virions nor infected T-cells.
The most important feature of these results is the explicit formula for RL, which can be related exactly
to the basic reproductive number of the three-component model (1). In order to investigate the differences
between the two reproductive ratios, we define the quantity
(5) Q :=
RL
R0
=
(1 − p)dL + α
dL + α
.
Notice that Q depends only upon the three new parameters included within (2), namely the activation
ratio α, proportion of cells which become latent upon infection p, and the death rate of latent cells dL.
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Additionally, if the proportion p of infections which produce latently infected T-cells is identically zero, then
RL = R0. However, since we consider p ∈ (0, 1) we find
Q <
dL + α
dL + α
= 1
and the relationship
RL < R0
follows directly. Thus, the reproduction number of the latent cell model (2) is strictly less than that of
the standard three-component model (1). Therefore, the stability of the the non-infective state is enhanced
by the inclusion of the latently-infected cell population. Namely, there are more values of λ, dT , dI , dV , k
and N which correspond to RL ≤ 1 than R0 ≤ 1. From a modeling standpoint, this result is somewhat
intuitive. Because (2) assumes that a fraction of newly infected cells become latently infected and the latter
can only activate (becoming actively productive) or die, the average number of infected cells generated by
the introduction of a single infected cell into a susceptible system is decreased in comparison to a model
without latently infected cells, namely (1). Hence, one should expect that the basic reproduction number,
representing this average number of infected cells, does in fact decrease. Another consequence of this results
is that there exist a number of parameter values for which R0 > 1 but RL ≤ 1, and in such cases the solutions
of (1) tend to ENI while those of (2) tend to EI as t → ∞. Clearly, the converse (R0 ≤ 1 but RL > 1) is
not possible by the above inequality. In fact, we may rewrite their ratio Q as
Q = 1−
pdL
dL + α
so that the difference between R0 and RL is greatest for large values of p and dL, but small values of α.
With the representative parameter values given in Table 1, we see that
RL ≈ 5.978 and R0 ≈ 6.154.
Hence, the change in system behavior caused by the difference between the reproduction numbers appears
somewhat negligible, as both values are significantly larger than their respective bifurcation points. Addi-
tionally, Q = 0.97 in this case, so that the relative difference between R0 and RL is merely
R0 −RL
R0
= 1−Q = 3%.
Exactly quantifying this relative change, however, is difficult since many of the parameter values of Table
1, in particular k, p, α, and dL, are not well-established, and hence this percentage could be much larger or
perhaps even smaller. For example, if we utilize the smallest value of α = 3 × 10−3, stemming from [24],
and the largest values of p = 0.1 [34] and dL = 0.24 [24], then a simple computation shows that Q = 0.9.
Hence, the relative difference between reproductive ratios could possibly be as large as 10%, though more
conservative estimates of the associated parameters place the value of 1−Q between 1% and 5%.
Regardless of the quantified distinction between the reproductive ratios, it seems somewhat counterintu-
itive that RL < R0, especially since so many authors [1, 2, 6, 7, 9, 10, 18, 19, 23, 28, 32] have detailed the large
degree to which latent reservoirs contribute to the increased persistence of HIV infection via viral rebound
after treatment with ART. Hence, the result of the mathematical analysis, namely that the effects of latent
infection reduce the basic reproductive ratio, seems to contradict this theory. However, as we previously
stated, the alterations in the mathematical model explain this effect. Additionally, the reproductive ratio is
but one parameter, and so it seems unlikely that this particular metric will completely determine the realistic
behavior of the system. In fact, a more detailed analysis of the behavior of solutions over the timescales
of biological relevance, rather than considering only the limiting behavior as t → ∞, will demonstrate the
shortcomings of the basic reproductive ratio. We illustrate this using the effects of antiretroviral therapy
and some associated computational results within the next section.
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4. Antiretroviral Therapy
In order to further contrast these two models and the effects of the latent cell population, we will introduce
additional parameters to represent the application of antiretroviral therapy. The inclusion of ART will allow
us to determine the range of drug efficacies that distinguish between the limiting dynamics of (1) and (2)
and further elucidate the differing behaviors of the two models.
Two classes of antiretroviral drugs are often used to reduce the viral load and limit the infected T-cell
population. One class is known as Reverse Transcriptase Inhibitors (RTIs), which can block the infection
of target T-cells by infectious virions. The other category is Protease Inhibitors (PIs), which prevent HIV-1
protease from cleaving the HIV polyprotein into functional units, thereby causing infected cells to produce
immature virus particles that are non-infectious. In this way, RTIs serve to reduce the rate of infection of
activated CD4+ T-cells, whereas PIs decrease the number of new infectious virions that are produced. Both
drugs thus diminish the propagation of the virus [17, 30]. While we expect that latently infected cells may
absorb PIs and that such cells, when activated, will produce noninfectious virus, we will instead assume that
PIs have no effect on the proportion of cells that are latently infected. This is in line with some experimental
findings, that suggest that antiretroviral drugs do not effectively block replication of virus from the latent
reservoir [8]. Hence, in our model, susceptible T-cells may be inhibited with either RTIs, or PIs, or they
may become infected. Infected cells may be inhibited with PIs, and cells inhibited with one drug may be
inhibited with the other. In the presence of these two inhibitors, the model equations (2) are modified to
become:
(6)


dT
dt
= λ− dTT − k(1− ǫRT )TVI
dI
dt
= (1− p)k(1− ǫRT )TVI + αL− dII
dL
dt
= pk(1− ǫRT )TVI − αL − dLI
dVI
dt
= N(1− ǫPI)dII − dV VI .
where ǫRT , ǫPI ∈ [0, 1] are the efficacies of RTIs and PIs, and VI represents the population of infectious
virions. We may include the number of non-infectious virions VNI , with the total viral load V = VI + VNI ,
but VNI decouples from the remaining equations, and hence plays no role in the evolution of the system.
To compute the steady states and basic reproduction number for (6), we may reproduce the analysis of
(2), but clearly the new terms are introduced only where the parameters k and N appear. Thus, we need
only replace k with k(1− ǫRT ) and N with N(1− ǫPI). The new basic reproduction number then becomes
(7) RǫL =
kN(1− ǫ)λ
dT dV
·
(1− p)dL + α
dL + α
where we define the quantity ǫ = ǫRT + ǫPI − ǫRT ǫPI , so that
1− ǫ = (1− ǫRT )(1− ǫPI).
Since (6) is identical to (2) with the minor change in parameter values described above, Theorems 3.2 and
3.3 hold for (6) with the corresponding value RǫL instead of RL. Writing the corresponding viral steady state
for (6) we find
V =
dTRL
k
(1− ǫPI)−
dT
k(1− ǫRT )
and we notice that its partial derivative
∂V
∂ǫRT
= −
dT
k(1− ǫRT )2
9
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Figure 3: Viral loads for (6) and (8) with ǫ = 0.519. This value of ǫ yields Rǫ0 = 1.003 and R
ǫ
L = 0.974,
respectively. The inset figure includes the viral behavior for t ∈ [0, 6000] days.
is large, especially when ǫRT ≈ 1. Thus, V is sensitive to small changes in ǫRT , and this sensitivity increases
with the efficacy of the RTI. Hence, this model does not realistically describe the persistence of low-level
viremia in patients on reverse transcriptase inhibitors, as previously addressed within [28]. However, we note
that
∂V
∂ǫPI
= −
dTRL
k
which is constant for all values of ǫPI , and does not possess the same sensitivity. Thus, to simplify the
analysis, we will assume throughout that only PIs are used, and hence ǫ = ǫPI while ǫRT = 0.
Upon incorporating the use of antiretroviral drugs into (1), the system becomes
(8)


dT
dt
= λ− dTT − k(1− ǫRT )TVI
dI
dt
= k(1− ǫRT )TVI − dII
dVI
dt
= N(1− ǫPI)dII − dV VI .
with associated basic reproduction number
(9) Rǫ0 =
kN(1− ǫ)λ
dTdV
.
As for (6), the stability results for (1) contained in Section 2 hold for (8) by replacing R0 with R
ǫ
0. Comparing
the two values Rǫ0 and R
ǫ
L, we see that their ratio is again Q given by (5), so that R
ǫ
L = QR
ǫ
0. As before,
since Q < 1 we find RǫL < R
ǫ
0 and even with the incorporation of ART, the latent cell population decreases
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the basic reproduction number of the system. With the representative parameter values given in Table 1,
we see that the basic reproduction numbers associated with (6) and (8) are
RǫL ≈ 2.027(1− ǫ) and R
ǫ
0 ≈ 2.087(1− ǫ).
Hence, in order for the non-infective state to be realized in (8), we must have ǫ > 0.521, which only differs
mildly from the value of ǫ that is needed to reach the same non-infective state in (6), namely ǫ > 0.506.
Thus, the antiretroviral therapy must attain an efficacy only 3% greater in order to achieve the analogous
effect. From this analysis, it would seem that the establishment of a latent reservoir should not strengthen
a continued infection since the drug efficacy necessary to drive the system to a non-infective equilibrium is
actually less for (6) than for (8). This result seems to greatly contradict the known issues that scientists have
faced regarding the eradication of the viral reservoir. However, the resolution of these seemingly opposing
viewpoints is made quite clear by precise numerical simulations.
As an illustrative example of the difference in long-time dynamics between the two models, we may choose
values of ǫ which yield Rǫ0 > 1 and R
ǫ
L < 1 and measure their corresponding behavior. A representative
simulation is presented in Figure 3. To differentiate between the corresponding viral loads, we will denote
the infectious virus population associated with (8) by V3CM (t) and its latent model analogue by VLatent(t)
as in the figure. In this case, we choose ǫ = 0.519 and find Rǫ0 = 1.003 and R
ǫ
L = 0.974. Hence, from the
known results of Section 2 and Theorem (3.3), we may deduce that V3CM (t) →
dT
k
(Rǫ0 − 1) ≈ 2 × 10
3 as
t→∞, while VLatent(t)→ 0 as t→∞. However, one can distinctly see from Figure 3 that the early decay
rate of V3CM is much greater than that of VLatent.
Notice that the effects of latent infection do not influence the viral load for the first thirty days of treatment
as V3CM (t) and VLatent(t) follow the same approximate trajectory during this time period. However, once
the latently infected T-cell population grows sufficiently large, the effects are tremendous. Throughout
the first three years of continuous treatment, V3CM diminishes greatly, past 10
−10 in fact, while VLatent
remains O(1) even up to day 1000. Certainly this seems strange as Rǫ0 > 1 implies a persistent virus
population must develop for (8) and RL < 1 dictates the eventual elimination of the viral population for the
latent model. Within the inset figure, it can be seen that the behavior predicted by the basic reproduction
numbers does eventually occur, that is, values of V3CM rebound and tend to a positive equilibrium, while
those of VLatent continue their slow, steady decline to eradication. Unfortunately, these events occur nearly
fifteen years after the introduction of ART and well outside the timescale of biological relevance. Hence, it
appears that the values of Rǫ0 and R
ǫ
L alone cannot provide sufficient information to account for the realistic
biological dynamics of the model due to the change in timescales and decay rates introduced by the latent cell
population. A better estimate of the behavior would certainly be given by the rates of decay to eradication,
but precise estimates on these quantities are more difficult to obtain analytically. Instead, we examine a
slightly different metric of viral persistence or clearance.
The feature of viral clearance that one must capture here is not just the decay of the viral load, but a
sufficiently rapid speed of decay so as to be realized within a time period of biological relevance. Hence, we
consider a specific value of the virus population to represent clearance, and proceed to study the minimum
arrival time of the viral load to that value. In this vein, we define the functions
Pn(r) = inf
{
t > 0 : log10
(
V3CM (t)
)
≤ −n for Rǫ0 = r
}
and
Qn(r) = inf
{
t > 0 : log10
(
VLatent(t)
)
≤ −n for RǫL = r
}
.
We note that either of these functions may become infinite if the population of virions fails to reach the
prescribed value for any positive time. For example, P5(2) = Q5(2) =∞, since neither viral load obtains a
value as small as 10−5 for a corresponding reproductive ratio of 2, while P5(0.6) ≈ 25 and Q5(0.6) ≈ 1000 as
represented in Figure 4. Unlike the stability of equilibria, the values of Pn(r) and Qn(r) will depend upon
the initial population values that are chosen. Within the present study, however, we will continue to utilize
the initial populations of previous sections to serve as a representative example.
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Figure 4: Comparison of P5(R
ǫ
0) and Q5(R
ǫ
L)
We first select the value of 10−5 copies per ml for our definition of viral eradication and study the
associated times to eradication provided by the functions P5 and Q5. Namely, what we are assuming is that
once the viral population is suitably dilute - in this case less that 10−5 copies per ml - then the infection
has been cleared and no rebound can occur. Figure 4 provides a comparison of P5 and Q5 for differing
values of Rǫ0 and R
ǫ
L, respectively. Though their general shapes are quite similar, the associated time periods
differ dramatically. Typical values of P5 range from 20 to 100 days, while the majority of values of Q5
range between 1000 and 3000 days. As can be seen in Figure 4, even if the efficacy of the RT inhibitor, ǫ,
approaches 100%, and thus Rǫ0 approaches zero, V3CM requires around 15 days to reach a value of 10
−5. In
this same situation, RǫL approaches zero, but VLatent requires nearly 500 to 1000 days to reach a value of
10−5. Thus, even for values of RǫL which are significantly less than one, we see that it would require nearly
three years for the viral load to reach this threshold due to the influence of latent infection. In addition, we
see that V3CM will reach values of 10
−5 even if Rǫ0 > 1, and this will occur within 100 days, almost ten times
faster than it would take VLatent to reach the same value for a constant drug efficacy around 90%.
Considering that the biological detection threshold is around 50 viral copies per ml [4,12], one possibility
is that the 10−5 threshold above has been chosen too small in Figure 4 to effectively serve as a realistic
measure of eradication. Hence, we consider P1 and Q1 and perform a similar analysis. Figure 5 contains
these simulations and displays a decrease in the time necessary to reach the defined threshold of 10−1.
However, even for a 70% constant drug efficacy, in which case RǫL = 0.6, we see that approximately one year
of continuous ART would still be required to reach a viral load of 0.1 copies per ml for (6). Additionally,
values of P1 remain around 60 for (8) even if R
ǫ
0 is near 1.5, which exceeds the bifurcation point by nearly
50%. Thus, if we define viral clearance as a decay in the viral load to 0.1 copies per ml within six months
of treatment, then (8) would require Rǫ0 to be less than 1.5 while (6) would require R
ǫ
L to be less than 0.2.
Obviously, a much wider range of parameter values will yield Rǫ0 < 1.5 than R
ǫ
L < 0.2, and we see that the
latent T-cell population does, in fact, extend the period of time during which viremia persists, even though
the behavior as t→∞, as given by Theorems 3.2 and 3.3, may provide seemingly contrary information.
From this, the biological influence of latent infection becomes clear - the time needed to decrease the
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Figure 5: Comparison of P1(R
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viral load to values from which rebound is unlikely or unable to occur is increased by a factor of ten or
twenty. Hence, the value of the basic reproduction number alone does not represent a proper definition for
viral persistence or eradication, and the functions provided above Pn(r) and Qn(r), for well-chosen values of
n, possess the information required to better determine the behavior of the infection. Further analysis can
be performed for smaller (and negative) values of n, but the results discussed above are typical. In the next
section, we prove Theorems 3.1, 3.2, and 3.3 regarding the qualitative behavior of the latent infection model.
5. Proofs of main theorems
With the analysis concluded, we finally prove the main results of the previous sections. In what follows,
C will be used to denote a positive, but arbitrary constant which may change from line to line. First, we
prove the existence, uniqueness, and positivity of solutions.
Proof (Theorem 3.1). While one may prove that a certain positive set remains invariant under the flow
(as in [13]), this requires assumptions which bound the initial data from above. In our proof, we utilize a
continuity argument instead and do not assume any upper bounds on initial data. Using the Picard-Lindeloff
theorem and the quadratic nature of the equation, the local-in-time existence of a unique, C1 solution follows
immediately. Hence, we will concentrate on proving positivity of solutions as long as they remain continuous,
and this property will yield bounds on the growth of solutions. From the bounds obtained below, then, it
follows that the solution exists globally and is both unique and continuously differentiable for all t > 0.
Define
T ∗ = sup{t ≥ 0 : T (s), I(s), L(s), V (s) > 0, for all s ∈ [0, t]}.
Since each initial condition is nonnegative and the solution is continuous, there must be an interval on which
the solution remains positive, and we see that T ∗ > 0. Then on the interval [0, T ∗] we estimate each term.
Lower bounds on I, L, and V instantly follow since the decay terms are linear. More specifically, we find
dI
dt
= (1− p)kTV + αL− dII ≥ −dII
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and thus
I(t) ≥ I(0)e−dIt > 0
for all t ∈ [0, T ∗]. Similarly, for the latent T-cell population
dL
dt
= pkTV − (dL + α)L ≥ −(dL + α)L
and thus
L(t) ≥ L(0)e−(dL+α)t > 0
for all t ∈ [0, T ∗]. The positivity of the virion population follows in the same manner since
dV
dt
= NdII − dV V ≥ −dV V
and thus
V (t) ≥ L(0)e−dV t > 0
for all t ∈ [0, T ∗]. The positivity of T requires extra effort since it decreases due to the nonlinearity. We first
construct an upper bound on dT
dt
as
dT
dt
= λ− µT − kTV ≤ λ
and thus
T (t) ≤ T (0) + λt ≤ C(1 + t).
Next, we sum the equations for I, L, and V , and by positivity of these functions, obtain upper bounds on
each one. Using the upper bound on T (t), we find
d
dt
(I + L+ V ) = kTV + (N − 1)dII − dLL− dV V ≤ C(1 + t) (I + L+ V ) .
By Gronwall’s Inequality, we have
I(t) + L(t) + V (t) ≤ Cet
2
for t ∈ [0, T ∗]. Since I(t) and L(t) are positive on this interval, the same upper bound follows on V (t) alone.
With this, we can now obtain a lower bound on T . We find
dT
dt
= λ− dTT − kTV ≥ −dTT − kTV ≥ −C(1 + e
t2)T
or stated equivalently
dT
dt
+ C(1 + et
2
)T ≥ 0.
It follows that
d
dt
(
T (t)eC
∫
t
0
(1+eτ
2
)dτ
)
≥ 0
and T (t) ≥ T (0)e−C
∫
t
0
(1+eτ
2
)dτ > 0 for t ∈ [0, T ∗]. Finally, if T ∗ <∞, then all functions are strictly positive
at time T ∗, contradicting its definition as the supremum of such values. Hence, we find T ∗ = ∞ and the
result follows.
Next, we prove the local stability results.
Proof (Theorem 3.2). We proceed by linearizing the system and using the Routh-Hurwitz criterion to
determine conditions under which the linear system possesses only negative eigenvalues. Then, as a conse-
quence of the Hartman-Grobman Theorem, the local behavior of the linearized system is equivalent to that
of the nonlinear system.
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First, we compute the Jacobian evaluated at the non-infective equilibrium ENI = (
λ
dT
, 0, 0, 0), resulting
in
J(ENI) =


−dT 0 0 −
kλ
dT
0 −dI α
k(1−p)λ
dT
0 0 −dL − α
kpλ
dT
0 NdI 0 −dV


From this, we compute the associated characteristic polynomial for eigenvalues η
0 = det(J − ηI)
= (dT + η)
[
(dI + η)(dL + α+ η)(dV + η)−
αNKλpdI
dT
−
NKλ(1− p)dI
dT
(
dL +
α
1− p
+ η
)]
.
After expanding the terms and ordering by powers of η, this equation ultimately simplifies to
(10) η3 +A1η
2 +A2η +A3 = 0
where
A1 = dV + dI + dL + α
A2 = dIdV + (dL + α)(dI + dV )−
(1− p)λNkdI
dT
A3 = (dL + α)dIdV −
λNkdI
dT
((1 − p)dL + α).
The Routh-Hurwitz criterion requires A1, A2, A3 > 0 and A1A2 − A3 > 0. Clearly, A1 > 0, and after
rewriting A3 in terms of RL, we find
A3 = (dL + α)dIdV (1−RL).
Thus, in order for all of the eigenvalues of the system to be negative, it is necessary that RL < 1. Similarly,
we rewrite A2 as
A2 = (dL + α)(dI + dV ) + dIdV
[
1−RL
(1− p)(dL + α)
(1− p)dL + α
]
.
Using the inequality
(11)
(1− p)(dL + α)
(1 − p)dL + α
= 1−
pα
(1 − p)dL + α
< 1,
and the previous condition RL < 1, we find A2 > 0.
Finally, using (11), we see that A2 > dIdV (1 −RL), and clearly A1 > dL + α. Therefore, we find
A1A2 > dIdV (dL + α)(1 −RL) = A3
and the Routh-Hurwitz criteria are satisfied. Thus, RL < 1 implies that all eigenvalues of the linearized
system are negative, and hence the local asymptotic stability of ENI follows. Conversely, if RL > 1, then
the linearized system possesses at least one positive eigenvalue, and the equilibrium is unstable.
The analysis for EI is similar to that of ENI . For notational purposes, we label the equilibrium as
(T¯ , I¯, L¯, V¯ ). Linearizing (2) about EI , we find the Jacobian
J(EI) =


−(dT + kV¯ ) 0 0 −kT¯
(1 − p)kV¯ −dI α k(1− p)T¯
pkV¯ 0 −dL − α kpT¯
0 NdI 0 −dV


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and this results in the characteristic equation
0 = (dTRL + η)(dI + η)(dL + α+ η)(dV + η)
−
NKλ(1− p)dI
dTRL
(
dL +
α
1− p
+ η
)
(dT + η).
After expanding terms and simplifying, we arrive at the quartic polynomial
η4 +A1η
3 +A2η
2 +A3η +A4 = 0
where
A1 = dTRL + dV + dI + dL + α
A2 = dTRL(dL + α+ dI + dV ) + (dL + α)(dI + dV ) + dIdV
−
(1− p)λNkdI
dTRL
A3 = dTRL(dL + α)(dI + dV ) + dTRLdIdV + (dL + α)dIdV
−
λNkdI
dTRL
((1− p)dT + (1 − p)dL + α)
A4 = dTRL(dL + α)dIdV −
λNkdI
RL
((1 − p)dL + α)
As before, the Routh-Hurwitz criterion requires all coefficients to be positive, as well as, A1A2−A3 > 0 and
now A3(A1A2 − A3) − A4A
2
1 > 0. As for the ENI analysis, the positivity of A1 follows directly from the
positivity of the coefficients, and after rewriting A4, we find
A4 = dT (dL + α)dIdV (RL − 1).
Hence, it is necessary that RL > 1 in order to satisfy the criteria. Similarly, we rewrite A3 as
A3 = dTRL(dL + α)(dI + dV ) + dTRLdIdV + (dL + α)dIdV
−
[
dTdIdV
(1− p)(dL + α)
(1− p)dL + α
+ dIdV (dL + α)
]
> dTRL(dL + α)(dI + dV ) + dT dIdV (RL − 1) > 0.
In this inequality we have canceled the third term with the last term and utilized the inequality (11) to
bound the fourth term. The only nonpositive term in A2 can be rewritten as
−
(1− p)λNkdI
dTRL
= −dIdV
(1− p)(dL + α)
(1 − p)dL + α
> −dIdV ,
and hence
A2 > dTRL(dL + α+ dI + dV ) + (dL + α)(dI + dV ) > 0.
By the definition of A1, we have A1 > dI + dV and using the above inequality for A2, we find
A1A2 > (dI + dV ) · [dTRL(dL + α+ dI + dV ) + (dL + α)(dI + dV )]
> (dI + dV ) · dTRL(dL + α) + dV · dTRLdI + dV · (dL + α)dI
> A3.
Finally, we verify the last inequality, namely A3(A1A2 − A3) − A4A
2
1 > 0. After a long calculation, we
find
A1A2 −A3 > (dL + α)
[
dTRL(dTRL + 2dI + 2dV + dL + α)
+(dL + α)(dI + 2dV ) + (dI + dV )
2
]
.
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Removing selected terms from the right side, we also find
(12) A1A2 −A3 > dI
[
(dL + α)
2 + (dL + α)dI + dTRL(dL + α)
]
.
In addition, we see from a previous computation that
A3 > dT dVRL(dL + α) + dT dIdV (RL − 1).
Hence, we obtain a lower bound for A3(A1A2−A3) by multiplying the first term in the inequality for A3 by
the right side of (12) and the second term of the A3 inequality by the previous lower bound for A1A2 −A3.
This results in
A3 (A1A2 −A3) > dTdVRL(dL + α) · dI
[
(dL + α)
2 + (dL + α)dI + dTRL(dL + α)
]
+dTdIdV (RL − 1)(dL + α)
[
dTRL(dTRL + 2dI + 2dV + dL + α)
+(dL + α)(dI + 2dV ) + (dI + dV )
2
]
> dTdIdV (RL − 1)(dL + α) · (dTRL + dV + dI + dL + α)
2
= A4A
2
1
With this, all of the criteria have been satisfied and EI is stable if RL > 1. Conversely, if RL < 1, then
the Jacobian possesses at least one positive eigenvalue, and the endemic state is unstable. Finally, the local
behavior of the system for R = 1 is implied by the result of Theorem 3.3.
Lastly, we include a proof of the previously stated global stability theorem.
Proof (Theorem 3.3). As in [20] for the case of (1), we will prove the global stability using a Lyapunov
function. We will denote the non-infective equilibrium by (T 0, 0, 0, 0). First, note that the quantity T (t)−
T 0 − T 0 ln
(
T (t)
T 0
)
vanishes when evaluated at T (t) = T 0 and is nonnegative as long as T (t) > 0 by a simple
application of Taylor’s Theorem. Next, define
U(t) = ((1 − p)dL + α)
[
T (t)− T 0 − T 0 ln
(
T (t)
T 0
)]
+ (dL + α)
[
I(t) +
1
N
V (t)
]
+ αL(t).
Notice that U is nonnegative, and U is identically zero if and only if it is evaluated at the non-infective
equilibrium point. We compute the derivative along trajectories and find
dU
dt
= ((1− p)dL + α)
(
1−
T 0
T
)
[λ− dTT − kTV ]
+ (dL + α)
[
(1− p)kTV + αL− dII +
1
N
(NdII − dV V )
]
+α [pkTV − (α + dL)L]
The I, L, and TV terms all cancel and after using the definition of T 0, we are left with
dU
dt
= ((1− p)dL + α) (λ− dTT )
(
1−
λ
dTT
)
+
[
((1 − p)dL + α) kT
∗ − (dL + α)
dV
N
]
V
= −
(1− p)dL + α
dTT
(λ − dTT )
2 +
(dL + α)dV
N
(RL − 1)V.
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Thus, under the assumption that RL ≤ 1, we see that
dU
dt
≤ 0 for all positive values of T, I, L, and V , and
the global asymptotic stability follows by LaSalle’s Invariance Principle.
Turning to the endemic equilibrium, none of the end values are zero, so we denote this steady state by
(T ∗, I∗, L∗, V ∗) and define
U(t) = ((1− p)dL + α)
[
T (t)− T ∗ − T ∗ ln
(
T (t)
T ∗
)]
+ (dL + α)
[
I(t)− I∗ − I∗ ln
(
I(t)
I∗
)
+
1
N
(
V (t)− V ∗ − V ∗ ln
(
V (t)
V ∗
))]
+ α
[
L(t)− L∗ − L∗ ln
(
L(t)
L∗
)]
.
As before, this function is nonnegative and identically zero only when evaluated at the endemic equilibrium.
Computing the derivative along trajectories yields
dU
dt
= ((1− p)dL + α)
(
1−
T ∗
T
)
[λ− dTT − kTV ]
+ (dL + α)
[(
1−
I∗
I
)
((1− p)kTV + αL− dII)
+
1
N
(
1−
V ∗
V
)
(NdII − dV V )
]
+ α
(
1−
L∗
L
)
[pkTV − (α + dL)L]
= ((1− p)dL + α) [λ− dTT − kTV ]
+ (dL + α)
[
(1− p)kTV + αL − dII +
(
dII −
dV
N
V
)]
+α [pkTV − (α+ dL)L]− ((1− p)dL + α)
[
λT ∗
T
− dTT
∗ − kT ∗V
]
−(dL + α)
[
(1− p)kTV I∗
I
+
αLI∗
I
− dII
∗ +
dIIV
∗
V
−
dV V
∗
N
]
+α
[
pkTV L∗
L
− (α + dL)L
∗
]
.
Nicely, the I, L, V , and TV terms all vanish and what remains is
dU
dt
= ((1 − p)dL + α)
[
λ− dTT + dTT
∗ −
λT ∗
T
]
+ (dL + α)
[
−(1− p)k
TV I∗
I
− α
LI∗
I
+ dII
∗ − dI
IV ∗
V
+ dV
V ∗
N
+ αL∗ −
αpk
dL + α
TV L∗
L
]
=: I + II.
For I, we factor out a dTT
∗ term and use the form of T ∗ to find
I = (dL + α)dTT
∗
[
RL + 1−
T
T ∗
−RL
T ∗
T
]
= (dL + α)dTT
∗
[
2−
T
T ∗
−
T ∗
T
+ (RL − 1)
(
1−
T ∗
T
)]
= (dL + α)dTT
∗
[
2−
T
T ∗
−
T ∗
T
]
+ (dL + α)dTT
∗(RL − 1)
(
1−
T ∗
T
)
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For II, we factor an L∗ term and use the identities
T ∗V ∗ =
dL + α
kp
L∗ and NdII
∗ = dV V
∗
to find
II = (dL + α)L
∗
[
α+
dII
∗
L∗
+
dV V
∗
NL∗
− (1− p)k
TV I∗
L∗I
−
dII
∗
L∗
IV ∗
I∗V
−
αpk
dL + α
TV
L
− α
LI∗
L∗I
]
= (dL + α)L
∗
[
α+
2((1− p)dL + α)
p
−
(1− p)(dL + α)
p
TV I∗
T ∗V ∗I
−
(1− p)dL + α
p
IV ∗
I∗V
− α
TV L∗
T ∗V ∗L
− α
LI∗
L∗I
]
=
(dL + α)L
∗
p
[
((1− p)dL + α)
(
2−
IV ∗
I∗V
)
− (1− p)(dL + α)
TV I∗
T ∗V ∗I
+ αp
(
1−
TV L∗
T ∗V ∗L
−
LI∗
L∗I
)]
Thus, combining the rearrangements of I and II, we find
dU
dt
= (dL + α)dTT
∗
[
2−
T
T ∗
−
T ∗
T
]
+ (dL + α)dTT
∗(RL − 1)
(
1−
T ∗
T
)
+
(dL + α)L
∗
p
[
((1 − p)dL + α)
(
2−
IV ∗
I∗V
)
− (1− p)(dL + α)
TV I∗
T ∗V ∗I
+ αp
(
1−
TV L∗
T ∗V ∗L
−
LI∗
L∗I
)]
The second term simplifies to combine with those in the third term since
(dL + α)dTT
∗(RL − 1) =
(dL + α)L
∗((1 − p)dL + α)
p
and therefore the expression becomes
dU
dt
= (dL + α)dTT
∗
[
2−
T
T ∗
−
T ∗
T
]
+
(dL + α)L
∗
p
[
((1− p)dL + α)
(
3−
T ∗
T
−
IV ∗
I∗V
)
− (1 − p)(dL + α)
TV I∗
T ∗V ∗I
+ αp
(
1−
TV L∗
T ∗V ∗L
−
LI∗
L∗I
)]
Since (1− p)(dL + α) = (1− p)dL + α− αp, we add and subtract αp within the first term of the second line
and place the extra components in the terms on the third line to arrive at
dU
dt
= (dL + α)dTT
∗
[
2−
T
T ∗
−
T ∗
T
]
+
(dL + α)L
∗
p
[
(1 − p)(dL + α)
(
3−
T ∗
T
−
TV I∗
T ∗V ∗I
−
IV ∗
I∗V
)
+ αp
(
4−
T ∗
T
−
TV L∗
T ∗V ∗L
−
LI∗
L∗I
−
IV ∗
I∗V
)]
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Finally, each of the resulting terms above are nonpositive because the arithmetic mean is greater than the
geometric mean, or more specifically,
1
2
(
T
T ∗
+
T ∗
T
)
≥
√
T
T ∗
·
T ∗
T
= 1
1
3
(
T ∗
T
+
TV I∗
T ∗V ∗I
+
IV ∗
I∗V
)
≥
3
√
T ∗
T
·
TV I∗
T ∗V ∗I
·
IV ∗
I∗V
= 1
1
4
(
T ∗
T
+
TV L∗
T ∗V ∗L
+
LI∗
L∗I
+
IV ∗
I∗V
)
≥
4
√
T ∗
T
·
TV L∗
T ∗V ∗L
·
LI∗
L∗I
·
IV ∗
I∗V
= 1.
Hence, dU
dt
≤ 0 for all positive values of T, I, L, and V . As in the non-infective case, the conclusion then
follows directly from LaSalle’s Invariance Principle.
6. Discussion
In order to realistically describe and predict the effects of latent HIV infection, models of HIV-1 dynamics
and the associated mathematical tools must be capable of explaining the rich set of dynamics inherent within
their formulation. We have explored the steady states and asymptotic behavior of the basic three-component
model and its well-known variant which includes the effects of latent infection. A rigorous analysis of the large
time behavior of these systems displays a reduction in the basic reproduction number due to the appearance
of the latently infected T-cell population, and at first glance seems contradictory to the known difficulties
of eradicating the latent reservoir with antiretroviral therapy. After undertaking a more detailed analysis
here, we find that even though the inclusion of latent T-cells allows for a wider range of parameter values to
induce viral eradication as t→∞, the rate at which this decay occurs under ART is retarded so significantly
that, in the majority of cases, the decay could only occur outside time periods of biological relevance. This
analysis highlights two major points. First and foremost, the latent cell population drastically extends the
lifespan of infection. This can be seen from the rates of decay displayed within Section 4 by the functions
P and Q. However, since this property cannot be detected at the level of the basic reproduction number,
a second major point becomes clear. The standard tools of computing equilibrium states and the differing
conditions under which a system may tend to these states as t→∞ is clearly insufficient to describe, or more
importantly predict, the realistic dynamics that these equations model. Hence, a more refined analysis which
investigates not only the end states, but the rate of propagation to a supposed equilibrium value within a
specified time period, is clearly needed to describe the propagation of HIV, at least when considering the
effects of latent infection.
Of course, our study is not all-inclusive. In attempting to address the question of latently infected cell
reservoirs, we have ignored other potential reservoirs of HIV, such as those occurring within the brain,
testicles, and dendritic cells [6]. The extent of viral replication in compartments other than resting CD4+ T-
cells in patients receiving antiretroviral therapy for extended periods of time has yet to be fully delineated.
One may also adapt the model to account for other viral reservoirs and incorporate the immune system
response to a viral load. In addition, we assumed the use of antiretroviral therapy that included only PIs.
Certainly, the effects of RTIs could also be included, though the picture becomes slightly more complex, and
the results are similar. One can also study effects arising from a number of additional aspects including
1. A secondary infective population, such as macrophages [13]
2. Pharmacological delays due to drug activation
3. The residual effects of decaying drug efficacy or periodic ART schedules
4. Spatial effects, such as those characterized by diffusion models and multiple compartment models
5. Uncertainty arising from the measurement of parameter values or fluctuations across populations of
individuals in the form of random coefficients or stochastic differential equations
6. Successive mutation of HIV virions
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That being said, the effects of the latent cell population on viral behavior have been clearly documented
within the current study, and it is greatly expected that even when additional mechanisms are incorporated
within the model, the basic reproduction number will not serve as a descriptive parameter alone since it only
describes the global asymptotic behavior of populations. Future work must examine the aforementioned
issues within the context of latent infection using the exponential decay functions, P and Q, as a refinement
of the mathematical analysis detailing the long time behavior of the model.
In conclusion, the dynamics of models that consider latent infection are so complex, even when spatial
fluctuations are ignored, that a single parameter, in this case RL or R
ǫ
L, cannot possibly dictate the realistic
behavior of the corresponding populations. Instead, one must consider a number of factors including the
time of validity inherent within the model, the average time periods underlying treatment, and the rates of
decay associated with the trend to equilbrium.
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